ZHONG D，ZHANG D，XIE T，et al. Biodegradable microalgae-based carriers for targeted delivery and imaging-guided therapy toward lung metastasis of breast cancer[J]. Small，2020，16（20）：e2000819.

WANG Z，ZHAO Y，YANG Z，et al. Construction of intelligent responsive drug delivery system and multi-mode imaging based on gold nanodots[J]. Macromol Rapid Commun，2022，43（10）：e2200034.

GUO Z，SUI J，MA M，et al. pH-responsive charge switcha- ble PEGylated ε-poly-l-lysine polymeric nanoparticles-assisted combination therapy for improving breast cancer treatment[J]. J Control Release，2020，326：350-364.

SINGH S，GHOSH C，ROY P，et al. Biosynthesis of folic acid appended PHBV modified copper oxide nanorods for pH sensitive drug release in targeted breast cancer therapy[J]. Int J Pharm，2022，622：121831.

MA W，SUN J，XU J，et al. Sensitizing triple negative breast cancer to tamoxifen chemotherapy via a redox-responsive vorinostat-containing polymeric prodrug nanocarrier[J]. Theranostics，2020，10（6）：2463-2478.

DONG C，ZHOU Q，XIANG J，et al. Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy[J]. J Control Release，2020，321：529-539.

TANG M X，YANG M J，HE K Y，et al. Glycyrrhetinic acid remodels the tumor microenvironment and synergizes with doxorubicin for breast cancer treatment in a murine model[J]. Nanotechnology，2021，32（18）：185702.

GUO Y，LIU S，LUO F，et al. A nanosized codelivery system based on intracellular stimuli-triggered dual-drug release for multilevel chemotherapy amplification in drug-resistant breast cancer[J]. Pharmaceutics，2022，14（2）：422.

ZHANG H，TANG W L，KHEIROLOMOOM A，et al. Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy[J]. J Control Release，2021，330：1080-1094.

LI R，LIN Z，ZHANG Q，et al. Injectable and in situ-formable thiolated chitosan-coated liposomal hydrogels as curcumin carriers for prevention of in vivo breast cancer recurrence[J]. ACS Appl Mater Interfaces，2020，12（15）：17936-17948.

TANG Z，LUO C，JUN Y，et al. Nanovector assembled from natural egg yolk lipids for tumor-targeted delivery of therapeutics[J]. ACS Appl Mater Interfaces，2020，12（7）：7984-7994.

LANDGRAF M，LAHR C A，KAUR I，et al. Targeted camptothecin delivery via silicon nanoparticles reduces breast cancer metastasis[J]. Biomaterials，2020，240：119791.

YADAV A S，RADHARANI N N V，GORAIN M，et al. RGD functionalized chitosan nanoparticle mediated targeted delivery of raloxifene selectively suppresses angiogenesis and tumor growth in breast cancer[J]. Nanoscale，2020，12（19）：10664-10684.

BHATTACHARYA S，GHOSH A，MAITI S，et al. Delivery of thymoquinone through hyaluronic acid-decorated mixed pluronic® nanoparticles to attenuate angiogenesis and metastasis of triple-negative breast cancer[J]. J Control Release，2020，322：357-374.

YIN S，GAO Y，ZHANG Y，et al. Reduction/oxidation-responsive hierarchical nanoparticles with self-driven degradability for enhanced tumor penetration and precise chemotherapy[J]. ACS Appl Mater Interfaces，2020，12（16）：18273-18291.

SHI J，REN Y，MA J，et al. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis[J]. J Nanobiotechnology，2021，19（1）：188.

KIM B，SHIN J，WU J，et al. Engineering peptide-targeted liposomal nanoparticles optimized for improved selecti- vity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy[J]. J Control Release，2020，322：530-541.

QIU Y，RENK，ZHAOW，et al. A “dual-guide” bioinspired drug delivery strategy of a macrophage-based carrier against postoperative triple-negative breast cancer recurrence[J]. J Control Release，2021，329：191-204.

GONG C，YU X，YOU B，et al. Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy[J]. J Nanobiotechnology，2020，18（1）：92.

DU W，CHEN C，SUN P，et al. Eliciting an immune hot tumor niche with biomimetic drug-based multi-functional nanohybrids augments immune checkpoint blockade-based breast cancer therapy[J]. Nanoscale，2020，12（5）：3317-3329.

MEI D，GONG L，ZOU Y，et al. Platelet membrane-cloaked paclitaxel-nanocrystals augment postoperative chemotherapeutical efficacy[J]. J Control Release，2020，324：341-353.

LI J Q，ZHAO R X，YANG F M，et al. An erythrocyte membrane-camouflaged biomimetic nanoplatform for enhanced chemo-photothermal therapy of breast cancer[J]. J Mater Chem B，2022，10（12）：2047-2056.

LI S，WU Y，DING F，et al. Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer[J]. Nanoscale，2020，12（19）：10854-10862.

HU M，ZHANG J，KONG L，et al. Immunogenic hybrid nanovesicles of liposomes and tumor-derived nanovesicles for cancer immunochemotherapy[J]. ACS Nano，2021，15（2）：3123-3138.

ZHAO Z，LI Y，SHUKLA R，et al. Development of a biocompatible copolymer nano complex to deliver VEGF siRNA for triple negative breast cancer[J]. Theranostics，2019，9（15）：4508-4524.

JUNEJA R，VADAREVU H，HALMAN J，et al. Combination of nucleic acid and mesoporous silica nanoparticles：optimization and therapeutic performance in vitro[J]. ACS Appl Mater Interfaces，2020，12（35）：38873-38886.

ZHANG Y，TENG Z，NI Q，et al. Orderly curled silica nanosheets with a small size and macromolecular loading pores：synthesis and delivery of macromolecules to eradicate drug-resistant cancer[J]. ACS Appl Mater Interfaces，2020，12（52）：57810-57820.

JIN M，HOU Y，QUAN X，et al. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties （Ⅱ）：co-delivery of paclitaxel and VEGF siRNA for synergistic breast cancer therapy in mice[J]. Int J Nanomedicine，2021，16：5479-5494.

LIU H，LIU C，YE L，et al. Nanoassemblies with effective serum tolerance capability achieving robust gene silencing efficacy for breast cancer gene therapy[J]. Adv Mater，2021，33（7）：e2003523.

LI Y，DING J，XU X，et al. Dual hypoxia-targeting RNAi nanomedicine for precision cancer therapy[J]. Nano Lett，2020，20（7）：4857-4863.

XU J，LIU Y，LI Y，et al. Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer[J]. Nat Nanotechnol，2019，14（4）：388-397.

LIU S，ZHANG Y，ZHAO X，et al. Tumor-specific silen- cing of tissue factor suppresses metastasis and prevents cancer-associated hypercoagulability[J]. Nano Lett，2019，19（7）：4721-4730.

LI G，GAO Y，GONG C，et al. Dual-blockade immune checkpoint for breast cancer treatment based on a tumor-penetrating peptide assembling nanoparticle[J]. ACS Appl Mater Interfaces，2019，11（43）：39513-39524.

ZHANG L，MU C，ZHANG T，et al. Development of targeted therapy therapeutics to sensitize triple-negative breast cancer chemosensitivity utilizing bacteriophage phi29 derived packaging RNA[J]. J Nanobiotechnology，2021，19（1）：13.

ZHANG L，MU C，ZHANG T，et al. Systemic delivery of aptamer-conjugated XBP1 siRNA nanoparticles for efficient suppression of HER2+ breast cancer[J]. ACS Appl Mater Interfaces，2020，12（29）：32360-32371.

ZHAO L，GU C，GAN Y，et al. Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis[J]. J Control Release，2020，318：1-15.

HA M，NAM S H，SIM K，et al. Highly efficient photothermal therapy with cell-penetrating peptide-modified bumpy Au triangular nanoprisms using low laser power and low probe dose[J]. Nano Lett，2021，21（1）：731-739.

TAHERI-LEDARI R，ZHANG W，RADMANESH M，et al. Multi-stimuli nanocomposite therapeutic：docetaxel targeted delivery and synergies in treatment of human breast cancer tumor[J]. Small，2020，16（41）：e2002733.

LI L，FU J，WANG X Y，et al. Biomimetic “nanoplatelets” as a targeted drug delivery platform for breast cancer theranostics[J]. ACS Appl Mater Interfaces，2021，13（3）：3605-3621.

ZHOU M，XING Y，LI X，et al. Cancer cell membrane camouflaged semi-Yolk@Spiky-shell nanomotor for enhanced cell adhesion and synergistic therapy[J]. Small，2020，16（39）：e2003834.

CHEN Y，ZHANG X H，CHENG D B，et al. Near-infrared laser-triggered in situ dimorphic transformation of BF2-azadipyrromethene nanoaggregates for enhanced solid tumor penetration[J]. ACS Nano，2020，14（3）：3640-3650.

ZHANG Y，WANG Q，MA T，et al. Tumor targeted combination therapy mediated by functional macrophages under fluorescence imaging guidance[J]. J Control Release，2020，328：127-140.

QIAO J，TIAN F，DENG Y，et al. Bio-orthogonal click-targeting nanocomposites for chemo-photothermal synergistic therapy in breast cancer[J]. Theranostics，2020，10（12）：5305-5321.

LIU R，AN Y，JIA W，et al. Macrophage-mimic shape changeable nanomedicine retained in tumor for multimodal therapy of breast cancer[J]. J Control Release，2020，321：589-601.

LIU P，PENG Y，ZHOU Y，et al. Rapamycin as a “one-stone-three-birds” agent for cooperatively enhanced phototherapies against metastatic breast cancer[J]. ACS Appl Mater Interfaces，2021，13（22）：25674-25684.

ZHU Y X，JIA H R，DUAN Q Y，et al. Photosensitizer-doped and plasma membrane-responsive liposomes for nuclear drug delivery and multidrug resistance reversal[J]. ACS Appl Mater Interfaces，2020，12（33）：36882-36894.

HU S，DONG C，WANG J，et al. Assemblies of indocyanine green and chemotherapeutic drug to cure established tumors by synergistic chemo-photo therapy[J]. J Control Release，2020，324：250-259.

YI H，LU W，LIU F，et al. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer[J]. J Nanobiotechnology，2021，19（1）：134.

WANG X，LIU Y，HU Y，et al. Hybrid micelles loaded with chemotherapeutic drug-photothermal agent realizing chemo-photothermal synergistic cancer therapy[J]. Eur J Pharm Sci，2022，175：106231.

TANG L，WANG Z，MU Q，et al. Targeting neutrophils for enhanced cancer theranostics[J]. Adv Mater，2020，32（33）：e2002739.

LI X，JEON Y H，KWON N，et al. In vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer[J]. Biomaterials，2021，266：120430.